NASDAQ

Barinthus Biotherapeutics plc - American Depositary Shares (BRNS)

517 Thanks from members

Barinthus Biotherapeutics (BRNS) is advancing its all-stock merger with Clywedog Therapeutics, culminating in a UK scheme of arrangement set for September 3, 2026, which will delist BRNS ADSs and transition trading to Nasdaq under the ticker CLYD.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →